Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Search for other papers by Mitsuhiro Fukushima in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Yuuki Takamura in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Search for other papers by Nobuyuki Amino in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
patients with honeycomb-like papillary thyroid carcinoma showing multiple small cysts, and describe the characteristic features on ultrasonography. Methods and Patients Ultrasonographic examination was performed by well-trained registered
Search for other papers by Haggi Mazeh in
Google Scholar
PubMed
Search for other papers by Amir Orlev in
Google Scholar
PubMed
Search for other papers by Ido Mizrahi in
Google Scholar
PubMed
Search for other papers by David J. Gross in
Google Scholar
PubMed
Search for other papers by Herbert R. Freund in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are both derived from the thyroid follicular cells. Of the two, PTC is the most common thyroid cancer, accounting for 75-80% of all thyroid
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Sara Carvalhal in
Google Scholar
PubMed
NOVA Medical School
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
life. Metastatic papillary thyroid carcinoma (PTC) with cutaneous metastases may cause pain, ulceration, and bleeding. Novel Insights ECT seems to be a safe and effective technique and may be an option for local palliative
Search for other papers by Filipe Pereira in
Google Scholar
PubMed
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto
Search for other papers by Sofia S. Pereira in
Google Scholar
PubMed
Search for other papers by Marta Mesquita in
Google Scholar
PubMed
Search for other papers by Tiago Morais in
Google Scholar
PubMed
Search for other papers by Madalena M. Costa in
Google Scholar
PubMed
Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto
Search for other papers by Pedro Quelhas in
Google Scholar
PubMed
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto
Search for other papers by Carlos Lopes in
Google Scholar
PubMed
Search for other papers by Mariana P. Monteiro in
Google Scholar
PubMed
Serviço de Endocrinologia, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction Malignant thyroid tumors provide a good model to study the mechanisms underlying the metastatic process. The most prevalent thyroid tumors are papillary (PTC) and follicular (FTC) carcinomas. Although both originate from
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
common somatic mutation in papillary thyroid carcinoma). What Does This Case Report Add? • We identified concurrent BRAF mutation and TSHR polymorphism for the first time in a case of hyperfunctioning malignant thyroid nodule. • The findings
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Search for other papers by Sule Canberk in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Joana C. Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Rui Batısta in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Andre F. Vieira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
well-established driver mutations [ 1 , 2 ]. Papillary thyroid carcinoma (PTC), the most common type (i.e., 90% of all thyroid malignancies) probably contributes to most such tumours in this “dark zone” [ 3 ]. Approximately 90% of thyroid cancers
Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore
Search for other papers by Hao Li in
Google Scholar
PubMed
Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel
Search for other papers by Nir Livneh in
Google Scholar
PubMed
Search for other papers by Snjezana Dogan in
Google Scholar
PubMed
Search for other papers by Ashok R. Shaha in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) are thyroid neoplasms derived from different cell types. While the former is common, the latter is much less frequent [ 1 , 2 ]. The synchronous occurrence
Search for other papers by Pedro Marques in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. The widespread use of neck ultrasound (US) has led to the identification of small asymptomatic thyroid nodules with indeterminate clinical relevance [ 1
Search for other papers by Inês Cosme in
Google Scholar
PubMed
Search for other papers by Ana Figueiredo in
Google Scholar
PubMed
Search for other papers by Sara Pinheiro in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The incidence of thyroid carcinoma (TC) increased over the past 50 years ( 1 , 2 ) mainly due to a disproportionate increase in small papillary TC ( 3 ). In 2020, the GLOBOCAN database reported worldwide 586,000 cases of TC
Search for other papers by Adile Begüm Bahçecioğlu in
Google Scholar
PubMed
Search for other papers by Alptekin Gürsoy in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Seyfettin Ilgan in
Google Scholar
PubMed
Search for other papers by Banu Bilezikçi in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Introduction Ultrasonographic (US) echogenic microfoci (EMF) are frequently seen in papillary thyroid carcinoma (PTC). European Thyroid Association, the American College of Radiology (ACR), and the Korean Society of Thyroid Radiology classify